TRENBOLONE ACETATE 100 MG/ML – 10 ML
Trenbolone Acetate 100 is an oil-based sterile injectable solution containing 100 mg/ml of trenbolone acetate. According to the supplied product information, it is formulated for intramuscular (IM) injection and is identified as a prescription product from Hilma Biocare.
Trenbolone acetate is an esterified form of trenbolone. The supplied information describes the acetate ester as fast acting, with serum trenbolone concentrations increasing rapidly following intramuscular administration and remaining elevated for several days. Trenbolone has both anabolic and androgenic properties and acts primarily through interaction with androgen receptors.
The product information describes anabolic steroids as synthetic derivatives of testosterone. Their effects can include changes in protein metabolism, nitrogen balance, endogenous testosterone production and reproductive hormone activity. Exogenous androgen administration may suppress the body’s natural testosterone production through feedback effects involving luteinising hormone (LH) and follicle-stimulating hormone (FSH). At higher exposure levels, spermatogenesis may also be suppressed.
The supplied pharmacological information states that trenbolone binds strongly to the androgen receptor. It also describes research suggesting possible interactions with progesterone and prolactin receptors, although the supplied material notes uncertainty surrounding some of these mechanisms. The source also discusses reported effects involving muscle anabolism, appetite, aggression and red blood cell production.
Because trenbolone has significant hormonal activity, its use can be associated with a broad range of adverse effects. Reported reactions in the supplied information include acne, increased body hair, male-pattern baldness, gynaecomastia, changes in libido, prolonged erections and reduced sperm production. Fluid and electrolyte retention may also occur.
The supplied safety information additionally reports possible gastrointestinal, hepatic, cardiovascular, neurological and haematological effects. These include nausea, changes in liver function tests, cholestatic jaundice, changes in serum lipids, hypertension, oedema, headache, anxiety, depression, irritability and changes in clotting factors. Severe behavioural or psychiatric changes are also specifically identified as a concern.
Trenbolone may interact with other medicines. The supplied information highlights the need for close monitoring in patients taking oral anticoagulants and notes that androgens can affect glucose metabolism and insulin sensitivity. It also states that trenbolone may alter cyclosporine metabolism and advises avoiding other hepatotoxic medicines.
The source lists several contraindications and precautions. These include known hypersensitivity to the ingredients, certain breast, prostate or testicular carcinomas, severe heart, liver or kidney disease, and a history of epilepsy. The supplied information states that androgen-containing products should not be used by women because of the potential for virilisation and fetal harm.
Monitoring is an important part of the supplied product information. Recommended parameters include serum cholesterol, HDL, LDL and triglycerides, haemoglobin and haematocrit, liver function tests, PSA, testosterone, dihydrotestosterone, estradiol, progesterone, prolactin and blood pressure. The source also recommends appropriate prostate assessment for relevant male patients.
Trenbolone Acetate 100 is presented as a 10 ml multiple-dose vial. The supplied storage instructions specify storage at 15–25°C in a cool, dry place and protection from light.
Because this is a prescription anabolic-androgenic steroid with potentially serious adverse effects, the supplied information should be considered alongside professional medical assessment. The product should not be used for self-medication, performance enhancement or purposes outside an appropriate medical indication.
Product Specifications
Product: Trenbolone Acetate 100
Strength: 100 mg/ml
Active Ingredient: Trenbolone acetate
Molecular Formula: C20H24O3
Molecular Weight: 312.40276 g/mol
CAS Number: 10161-34-9
Dosage Form: Injectable, oil-based sterile solution
Route: Intramuscular injection
Market Status: Prescription
Company: Hilma Biocare
Presentation: 10 ml multiple-dose vial
Indications
The supplied product information describes use in adult males where substantial weight gain and increased musculature may be required following substantial loss of body mass, particularly where caloric intake is limited and other anabolic therapies have failed.
Any therapeutic use should be determined by a qualified healthcare professional after consideration of the potential risks and benefits.
Clinical Pharmacology
Trenbolone is an anabolic-androgenic steroid that acts strongly through the androgen receptor. Exogenous anabolic-androgenic steroids can suppress endogenous testosterone production through feedback inhibition of LH and FSH.
The supplied information also describes potential effects involving androgen, progesterone and prolactin receptors and notes that some aspects of trenbolone’s pharmacology remain uncertain.
Adverse Reactions
Reported adverse reactions include:
Gynaecomastia
Oligospermia
Acne and increased body hair
Male-pattern baldness
Fluid and electrolyte retention
Nausea
Changes in liver function
Cholestatic jaundice
Changes in serum lipids
Hypertension and oedema
Headache and anxiety
Depression, irritability and agitation
Changes in libido
Priapism
Sleep-apnoea exacerbation
Changes in clotting factors
Severe behavioural or psychiatric changes are also identified in the supplied information.
Drug Interactions
The supplied information highlights potential interactions with:
Oral anticoagulants — close monitoring may be required.
Antidiabetic medicines — androgen therapy may affect glucose metabolism or insulin sensitivity.
Cyclosporine — metabolism may be affected.
Other hepatotoxic medicines — the supplied information advises avoidance.
Contraindications
The supplied information lists contraindications including:
Known hypersensitivity to the product’s ingredients
Known or suspected breast, testicular or prostate carcinoma
Severe heart disease
Severe liver disease
Severe kidney disease
History of epilepsy
Use in women because of potential virilisation and fetal harm
Precautions & Monitoring
The source advises medical supervision and monitoring of:
Serum cholesterol, HDL, LDL and triglycerides
Haemoglobin and haematocrit
AST/ALT and other hepatic function tests
PSA
Total, free and bioavailable testosterone
Dihydrotestosterone and estradiol
Progesterone and prolactin
Blood pressure
The supplied information also recommends appropriate prostate evaluation for male patients over 40 and continued periodic assessment where clinically appropriate.
Dosage & Administration
The supplied source states an adult-male regimen of 50–100 mg by IM injection every 3 days for a maximum duration of 4 weeks under physician care.
Because this is a prescription anabolic-androgenic steroid and individual treatment requirements can differ, dosing should only be determined and supervised by a qualified healthcare professional.
Presentation
Trenbolone Acetate 100 mg/ml — 10 ml multiple-dose vial.
Storage
Store in a cool, dry place at 15–25°C.
Protect from light.
